Biotechnology in Belgium

Biotechnology

Publication Date	September 2009
Publisher	Datamonitor
Product Type	Report
Pages	34
ISBN Number	not applicable
Product Code	DAT00624

Buy this product or for assistance call +44 20 7060 7474

PDF £150.00$250 | €168

FAX Order above formats by FAX

Summary

Datamonitor's Biotechnology in Belgium industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

Contains an executive summary and data on value, volume and/or segmentation
Provides textual analysis of the industry's recent performance and future prospects
Incorporates in-depth five forces competitive environment analysis and scorecards
Includes a five-year forecast of the industry
The leading companies are profiled with supporting key financial metrics
Supported by the key macroeconomic and demographic data affecting the market

Highlights

Detailed information is included on market size, measured by value and/or volume
Five forces scorecards provide an accessible yet in depth view of the market's competitive landscape

Why you should buy this report

Spot future trends and developments
Inform your business decisions
Add weight to presentations and marketing materials
Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2008 annual average exchange rates.

For the purpose of this report Europe is deemed to comprise of Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden, the Ukraine and the United Kingdom.

Content

Executive Summary
Chapter 1 Market Overview
- 1.1 Market Definition
- 1.2 Research Highlights
- 1.3 Market Analysis
Chapter 2 Market Value
Chapter 3 Market Segmentation I
Chapter 4 Market Segmentation Ii
Chapter 5 Five Forces Analysis
- 5.1 Summary
- 5.2 Buyer Power
- 5.3 Supplier Power
- 5.4 New Entrants
- 5.5 Substitutes
- 5.6 Rivalry
Chapter 6 Leading Companies
- 6.1 GlaxoSmithKline Plc
- 6.2 UCB Group
- 6.3 Amgen Inc
- 6.4 Innogenetics N V
Chapter 7 Market Forecasts
- 7.1 Market Value Forecast
Chapter 8 Macroeconomic Indicators
Chapter 9 Appendix
- 9.1 Methodology
- 9.2 Industry Associations
- 9.3 Related Datamonitor Research
List of Tables
- Table 1: Belgium Biotechnology Market Value: $ billion, 2004-2008
- Table 2: Belgium Biotechnology Market Segmentation I: % Share, by Value, 2008
- Table 3: Belgium Biotechnology Market Segmentation II: % Share, by Value, 2008
- Table 4: Key Facts: GlaxoSmithKline Plc
- Table 5: Key Financials: GlaxoSmithKline Plc
- Table 6: Key Facts: UCB Group
- Table 7: Key Financials: UCB Group
- Table 8: Key Facts: Amgen Inc
- Table 9: Key Financials: Amgen Inc
- Table 10: Key Facts: Innogenetics N V
- Table 11: Key Financials: Innogenetics N V
- Table 12: Belgium Biotechnology Market Value Forecast: $ billion, 2008-2013
- Table 13: Belgium Size of Population (million) , 2004-2008
- Table 14: Belgium GDP (Constant 2000 Prices, $ billion), 2004-2008
- Table 15: Belgium Inflation, 2004-2008
- Table 16: Belgium Exchange Rate, 2004-2008